IRV Exhaust and Vacuum Pump Replacement
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
75F40126R00049
NAICS
236220 - Commercial and Institutional Building Construction
Classification Code
Z2DB
Additional Details
The U.S. Food and Drug Administration (FDA), through its Office of Acquisitions and Grants Services (OAGS), has issued Solicitation 75F40126R00049 for the IRV Lab Exhaust & Vacuum Pump Replacement Project at the FDA Pacific Southwest Laboratory, located at 19701 Fairchild Road, Irvine, California. This procurement seeks a qualified contractor to undertake a comprehensive replacement of the laboratory vacuum pump system and the installation of a new laboratory exhaust system, ensuring the facility’s continued compliance with operational and safety standards.
The scope of work encompasses the provision of all necessary labor, materials, equipment, supervision, permits, and related services required for the removal and replacement of the existing vacuum pump system. Additionally, the contractor will be responsible for the installation of a new laboratory exhaust system, integration with the Building Automation System (BAS), testing and balancing (TAB), commissioning, and the provision of training and project closeout activities. The project’s requirements are detailed in the solicitation and associated Scope of Work documents, which are available through the official SAM.gov notice.
This solicitation is being conducted as a full and open competition, with no set-aside restrictions, under NAICS code 236220 (Commercial and Institutional Building Construction) and Product Service Code Z2DB. The FDA emphasizes that all interested offerors must attend a mandatory site visit scheduled for Wednesday, July 22, 2026, at 8:30 a.m. Pacific Time at the project location. Registration for the site visit is required by 12:00 p.m. Pacific Time on Monday, July 20, 2026, and each company may send up to three representatives. All attendees must present valid government-issued photo identification and comply with FDA security protocols. Attendance at the site visit is a strict prerequisite for proposal consideration; proposals from firms that do not attend will not be evaluated.
The procurement process includes the issuance of Amendment 0001, which provides the Government’s responses to questions received and incorporates revisions to the solicitation documents. Offerors are required to review all amendments and revised attachments in their entirety and acknowledge receipt as part of their proposal submission, in accordance with solicitation instructions.
Proposals are due by August 20, 2026, at 12:00 p.m. Eastern Time. Offerors must maintain active registration in SAM.gov at the time of proposal submission, throughout the evaluation period, and prior to contract award. All solicitation documents, attachments, and amendments are accessible via the SAM.gov opportunity posting.
The contracting activity is managed by the FDA Office of Acquisitions and Grants Services, under the Department of Health and Human Services. The primary point of contact for this solicitation is Sheneil Green ([email protected], 301-796-0675), with L. Maria Finan ([email protected], 240-402-5712) serving as the secondary contact.
This opportunity is ideal for contractors with demonstrated experience in commercial and institutional building construction, particularly those with expertise in laboratory mechanical systems, BAS integration, and commissioning. The project’s requirements for comprehensive project management, technical proficiency, and adherence to federal security and operational protocols will remain constant throughout the contract lifecycle.
Documents16